Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Receives $57.38 Average Target Price from Brokerages
Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Free Report) have been given an average rating of “Buy” by the nine analysts that are currently covering the firm, MarketBeat.com reports. Nine equities research analysts have rated the stock with a buy recommendation. The average 1 year target price among brokers that have updated their coverage […]
Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Free Report) have been given an average rating of “Buy” by the nine analysts that are currently covering the firm, MarketBeat.com reports. Nine equities research analysts have rated the stock with a buy recommendation. The average 1 year target price among brokers that have updated their coverage […]
